# Echo-Guided vs Fluoroscopy-Guided Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis（ECHO-TAVR）

Study · id `cardio:ct-nct07317804` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07317804](<https://clinicaltrials.gov/study/NCT07317804>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07317804

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 212 participants.

## Technical summary

Registry record NCT07317804. Randomized; no masking; primary purpose treatment. Start 2026-04-26 (anticipated); primary completion 2028-07-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 212 participants (planned count; ClinicalTrials.gov record NCT07317804, source copy `cardio:ctgov-nct07317804-2026-04-21`, retrieved 2026-10-26)
- Planned start: 2026-04-26 (anticipated) (ClinicalTrials.gov record NCT07317804, source copy `cardio:ctgov-nct07317804-2026-04-21`, retrieved 2026-10-26)
- Primary completion: 2028-07-30 (anticipated) (ClinicalTrials.gov record NCT07317804, source copy `cardio:ctgov-nct07317804-2026-04-21`, retrieved 2026-10-26)
- Completion: 2028-07-31 (anticipated) (ClinicalTrials.gov record NCT07317804, source copy `cardio:ctgov-nct07317804-2026-04-21`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07317804, source copy `cardio:ctgov-nct07317804-2026-04-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07317804-2026-04-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: Echo-Guided vs Fluoroscopy-Guided Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis（ECHO-TAVR）
- Acronym: ECHO-TAVR
- Condition: Aortic Stenosis
- Condition: TAVI
- Condition: TAVI(Transcatheter Aortic Valve Implantation)
- Intervention (Device): Echocardiographic guidance
- Intervention (Device): Fluoroscopic guidance
- Lead sponsor: China National Center for Cardiovascular Diseases
- Lead sponsor class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: China National Center for Cardiovascular Diseases (`cardio:org-china-national-center-for-cardiovascular-diseases`)

## Provenance

Content hash: 89969c41aeaf40606c07f80ad65c627ba95099fcb13d455e84508fcdaa9c7526
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
